Dad-turned-CEO inks Pfizer deal for Duchenne drugs
September 09, 2014 at 12:23 PM EDT
Ilan Ganot formed a drug development company, which is now looking into three initiatives to treat his 4-year-old son's disease, Duchenne muscular dystrophy.